🚨 Why Are Cisplatin & Carboplatin in Short Supply in India in 2026?

Imagine arriving at a hospital for your scheduled cancer treatment and being told that an essential chemotherapy medicine isn't available.

This is the situation that has raised concern across India in 2026, as hospitals and cancer centres have faced shortages of cisplatin and carboplatin, two widely used platinum-based chemotherapy medicines.

But why can an established medicine suddenly become difficult to find?

🧬 Why Are Cisplatin and Carboplatin Important?

Cisplatin and carboplatin are platinum-based chemotherapy medicines used in the treatment of several cancers, including lung, ovarian, cervical, bladder, head and neck and other cancers.

Because they are used across multiple treatment protocols, a shortage can affect patients across different types of cancer rather than being limited to one particular disease.

🚨 Why Did the Shortage Happen?

A medicine shortage isn't always caused by one simple problem.

In the case of cisplatin and carboplatin, reports in 2026 have pointed to several pressures occurring at the same time.

These include:

Rising prices of platinum, an important raw material
Higher manufacturing costs
API and supply-chain disruptions
Global supply difficulties
Concerns about whether production remained commercially viable at existing regulated prices

When the cost of producing a medicine rises significantly while its selling price remains constrained, manufacturers may face difficulty maintaining production and supply.

This is one of the less visible reasons why an essential medicine can become difficult to source.

💰 Why Does Medicine Pricing Matter to Availability?

It may seem strange that the price of a medicine could contribute to a shortage.

But pharmaceutical manufacturing has costs at every stage from raw materials and APIs to manufacturing, quality testing, packaging and distribution.

For scheduled medicines in India, pricing is regulated under the country's drug-pricing framework.

In June 2026, the National Pharmaceutical Pricing Authority (NPPA) approved a one-time 50% increase in the ceiling prices of cisplatin and carboplatin after concerns were raised about supply and rising input costs. The measure was intended to support continued availability.

This highlights an important point:

Affordable medicine and reliable medicine availability both matter.

🏥 What Does a Shortage Mean for Patients?

A shortage doesn't automatically mean that every patient will miss treatment.

Availability can differ between hospitals, cities, manufacturers and distributors.

However, prolonged shortages can create serious logistical challenges. Hospitals may need to search for available stock, coordinate with other suppliers or discuss medically appropriate alternatives with the treating team. Reports from Indian hospitals in 2026 have described patients and families searching multiple facilities for supplies.

⚠️ What Should Patients Do If Their Medicine Is Unavailable?

The most important thing is:

Don't try to solve a chemotherapy shortage by yourself.

If cisplatin or carboplatin prescribed for your treatment isn't available:

Speak to your oncologist or treating hospital.
Ask whether the hospital can source the medicine through another authorised supplier.
If an alternative treatment is medically appropriate, allow your oncologist to decide.
Do not purchase chemotherapy medicines from unknown or unverified sellers simply because they claim to have stock.
Keep your prescription and purchase documentation.

Whether another medicine can be used depends on the specific cancer, treatment protocol and individual patient.

🔎 What Does This Shortage Teach Us?

The 2026 cisplatin and carboplatin shortage shows something patients don't always see:

Medicine availability depends on much more than whether a drug has been approved.

Manufacturing capacity, raw materials, pricing, international supply chains, demand and distribution can all influence whether a medicine is available when it is needed.

For essential oncology medicines, problems anywhere along that chain can eventually reach the hospital and ultimately the patient.

The Bottom Line

Cisplatin and carboplatin remain important medicines in cancer treatment, but their supply has come under pressure in India during 2026.

The government has taken pricing measures intended to support availability, while hospitals and healthcare professionals continue to manage supply challenges.

For patients, the message is simple:

If your prescribed chemotherapy medicine is unavailable, don't panic and don't independently substitute or delay treatment. Speak with your oncology team and use authorised medicine-supply channels.

Macarius Health Perspective

At Macarius Health, we believe access to specialty medicines involves more than simply knowing which medicine is prescribed.

Availability, sourcing, storage, distribution and responsible supply are all part of the journey from manufacturer to patient.

Understanding these challenges helps patients and healthcare professionals see the bigger picture behind medicine availability.

Important Note

This article is for general educational purposes and does not provide individual cancer-treatment advice. Patients should follow the treatment plan provided by their oncologist. Never change, delay or substitute a chemotherapy medicine without guidance from the treating healthcare team.